A self-directed Trojanbot-enzymatic nanobot in neutrobot for active target therapy of glioblastoma
Abstract Chemotherapy is an important treatment for glioblastoma (GBM) and a key component of comprehensive GBM therapy. However, the blood-brain barrier (BBB) and complex tumor microenvironment (TME) restrict the diffusion of drugs, which greatly reduces the chemotherapeutic effect on GBM. Single s...
Saved in:
| Main Authors: | Yuanyuan Gao, Meng Mao, Yue Li, Mingjun Xuan, Yingjie Wu, Qiang He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60422-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Externally controlled intermittent randomization enables complex navigation of multiple nanobots
by: Rahul Goyal, et al.
Published: (2025-03-01) -
Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions
by: Justin Tang, et al.
Published: (2025-03-01) -
New Enzymatic Targets for Organophosphorus Compounds
by: E. N. Efremenko, et al.
Published: (2023-05-01) -
Synthesis of Epoxyoxirenes: Phytotoxic Activity and Enzymatic Target Identification
by: Kamylla C. F. de Faria, et al.
Published: (2025-06-01) -
Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
by: Jun Yang, et al.
Published: (2025-04-01)